FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Dimethyl topics
Physiologic
Hydrochloric Acid
Fresnel Zone
Aberration
Ophthalmic
Liquid Crystal
Imaging System
Pharmaceutically Acceptable Salt
Pharmaceutically Acceptable Salts
Chloric Acid
Tartaric Acid
Fumaric Acid
Antagonist
Bradykinin
Enantiomer

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Dimethyl patents



      
           
This page is updated frequently with new Dimethyl-related patent applications. Subscribe to the Dimethyl RSS feed to automatically get the update: related Dimethyl RSS feeds. RSS updates for this page: Dimethyl RSS RSS


Date/App# patent app List of recent Dimethyl-related patents
10/09/14
20140303323
 Methods for preparation of polyester/glyoxalated polyvinyl alcohol semi-interpenetrating polymer network hot-melt adhesive patent thumbnailMethods for preparation of polyester/glyoxalated polyvinyl alcohol semi-interpenetrating polymer network hot-melt adhesive
A polyester/glyoxalated polyvinyl alcohol semi-interpenetrating polymer network hot-melt adhesive and preparation method therefore, mainly inlcudes the steps of: 1) transesterification of certain amounts of dimethyl terephthalate and another dibasic ester with 1,4-butanediol and other diols in the presence of an organotin catalyst under a nitrogen atmosphere in a reactor, completed upon the amount of distillation of a monohydric alcohol byproduct reaching greater than 95% of the theoretical amount; 2) after the temperature is maintained for a period of time, adding in a stabilizer and a polycondensation catalyst and incrementally increasing the temperature to trigger a polycondensation reaction under a reduced pressure to produce particles of a copolymer, and freezing and pulverizing the copolymer particles to produce a powder of a copolyester; 3) uniformly blending a polyvinyl alcohol/glyoxal mixture with the powder produced in step 2) at ambient temperature to produce the target product. The product is capable of forming an internal semi-interpenetrating network at application temperatures..
10/09/14
20140303265
 Demulsification compositions, systems and methods for demulsifying and separating aqueous emulsions patent thumbnailDemulsification compositions, systems and methods for demulsifying and separating aqueous emulsions
The present invention provides compositions, systems and methods for demulsifying an emulsion including an aqueous phase and an organic phase by adding an effective amount of a composition comprising at least one quaternary organopolysiloxane or salt thereof to the emulsion, the composition optionally including at least one of quaternary epihalohydrin/polyamine copolymers or salts, and/or (poly)diallyldimethylammonium halides.. .
10/09/14
20140303195
 Combination patent thumbnailCombination
A novel combination comprising the mek inhibitor n-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)6,8-dimethyl;-2,4,7-trioxo-3,4,6,7-tetrahydro-2h-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, with a mtor inhibitor, pharmaceutical compositions comprising the same and methods of using such combinations and compositions in the treatment of conditions in which the inhibition of mek and/or mtor is beneficial, e.g. Cancer..
10/09/14
20140303052
 Thickened grease composition patent thumbnailThickened grease composition
A thickened grease composition is provided by process of heating a mineral oil and 12-hydroxystearic acid with lithium hydroxide and forming a simple lithium grease to which at least one component selected from the group comprising succinic acid, glutaric acid, adipic acid, 6-hydroxycaproic acid, dimethyl succinate, dimethyl glutarate, dimethyl adipate, methyl hydroxycaproate, cyclohexanediols, methyl 5-hydroxyvalerate, methyl valerate, gamma butyrolactone, and methyl levulinate or mixtures thereof.. .
10/09/14
20140302174
 Combination therapy for ovarian cancer patent thumbnailCombination therapy for ovarian cancer
The present invention provides a method of treating ovarian cancer in a mammal in need of such treatment comprising administering an effective amount of a combination of gemcitabine, cisplatin or carboplatin, and 5-[2-tert-butyl-5-(4-fluoro-phenyl)-1h-imidazol-4-yl]-3-(2,2-dimethyl-propyl)-3h-imidazo[4,5-b]pyridin-2-ylamine.. .
10/09/14
20140301957
 Enamel protectant and repair brushing gels patent thumbnailEnamel protectant and repair brushing gels
Substantially aqueous-free, enamel protectant and repair brushing gels containing: stannous fluoride, calcium and a substantivity agent comprising: an emulsion of polydimethylsiloxane in a nonionic surfactant, wherein substantivity of said stannous fluoride and calcium into biofilm present on enamel is enhanced through calcium binding shifting from bidentate to monodentate in the presence of stannous fluoride; and said brushing gels have substantially improved, enamel protectant factor (epf) and enamel repair factor (erf) values compared to fluoride brushing treatments with comparable or higher fluoride levels.. .
10/09/14
20140301956
 Methods for protecting and reparing enamel patent thumbnailMethods for protecting and reparing enamel
A method of treatment for enamel with substantially aqueous-free, enamel protectant and repair brushing gels containing: stannous fluoride, calcium and a substantivity agent comprising: an emulsion of polydimethylsiloxane in a nonionic surfactant, wherein substantivity of said stannous fluoride and calcium into biofilm present on enamel is enhanced through calcium binding shifting from bidentate to monodentate in the presence of stannous fluoride; and said brushing gels have substantially improved, enamel protectant factor (epf) and enamel repair factor (erf) values compared to fluoride brushing treatments with comparable or higher fluoride levels.. .
10/09/14
20140299021
 Non-aqueous solvent composition and its use as barrier liquid patent thumbnailNon-aqueous solvent composition and its use as barrier liquid
A non-aqueous solvent composition comprising 0 to 10 wt. % of n-alkyl pyrrolidone, 0 to 5 wt.
10/02/14
20140296600
 Production of para-xylene by catalytically reacting 2,5-dimethylfuran and ethylene in a solvent patent thumbnailProduction of para-xylene by catalytically reacting 2,5-dimethylfuran and ethylene in a solvent
The present invention provides a renewable route to para-xylene via cycloaddition of ethylene and 2,5-dimethylfuran and subsequent dehydration with high selectivity and high yields using acidic heterogeneous catalysts and a solvent for 2,5-dimethylfuran. The use of a solvent shows significant effects in the reduction of competing side reactions including hydrolysis of 2,5-dimethylfuran to 2,5-hexanedione, alkylation of p-xylene, and polymerization of 2,5-hexanedione..
10/02/14
20140296573
 Method of making a templating agent patent thumbnailMethod of making a templating agent
A method for preparing 1-adamantyltrimethylammonium hydroxide is disclosed. The method comprises reacting 1-adamantyldimethylamine with dimethyl carbonate to produce 1-adamantyltrimethylammonium methylcarbonate, which is then reacted with calcium hydroxide or magnesium hydroxide in the presence of water to produce 1-adamantyltrimethylammonium hydroxide..
10/02/14
20140296425
Telechelic based networks from novel macromonomers, compositions, preparation and uses thereof
The invention provides highly resilient synthetic hydrogels, which can be prepared, for example, by using the efficient thiol-norbornene chemistry to cross-link hydrophilic poly(ethylene glycol) (peg) and hydrophobic polydimethylsiloxane (pdms) polymer chains. The simple hydrogel system with enhanced mechanical properties is useful in many applications, including in the biomedical field and in the design of protective and corrective wear..
10/02/14
20140296422
Resin composition and molded body
Provided is a resin composition having weather resistance and low-temperature impact resistance, which are the problems of a poly(1,4-cyclohexylene dimethylene terephthalate) copolyester resin, and sustaining the chemical resistance and room-temperature impact resistance of poly(1,4-cyclohexylene dimethylene terephthalate) copolyester resin. It is a resin composition containing a poly(1,4-cyclohexylene dimethylene terephthalate) copolyester resin and a polycarbonate resin, in which the poly(1,4-cyclohexylene dimethylene terephthalate) copolyester resin is contained at 60 to 95% by weight and the polycarbonate resin is contained at 5 to 40% by weight..
10/02/14
20140296346
Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
A hitherto unknown crystalline form of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride, pharmaceutical compositions containing the new crystalline form, methods of producing the new crystalline form, and a related method of use including treatment of, e.g., pain and/or urinary incontinence.. .
10/02/14
20140296267
Solid dispersions of a erb2 (her2) inhibitor
A solid dispersion of n4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-n6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of n4-(4-([1,2,4]triazolo[1,5-α]pyridin-7-yloxy)-3-methylphenyl)-n6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein..
10/02/14
20140296213
New polymorph
The invention provides a new polymorph of 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzyl-carbamoyl)-l-proline-n,n-dimethylamide, pharmaceutical compositions containing it and its use in therapy.. .
10/02/14
20140295449
Screening method for selected amino lipid-containing compositions
The invention features a method of identifying therapeutically relevant compositions which include a therapeutic agent and 2,2-dilinoley 1-4-dimethylaminomethyl-[1,3]-dioxolane by screening for an effect of the agent on the liver of a model subject.. .
10/02/14
20140294741
Enamel protectant and repair toothpaste treatments
Substantially aqueous-free, enamel protectant and enamel repair toothpaste treatments containing: stannous fluoride, calcium and a substantivity agent comprising: an emulsion of polydimethylsiloxane in a nonionic surfactant, wherein: (a) substantivity of said stannous fluoride and calcium into biofilm present on enamel is enhanced through calcium binding shifting from bidentate to monodentate in the presence of stannous fluoride; and (b) said toothpaste treatments indicate substantially improved, enamel protectant factor (epf) and enamel repair factor (erf) values compared to fluoride brushing treatments with comparable or higher fluoride levels.. .
10/02/14
20140294032
Solid-state dye laser medium and process for production thereof
The challenge of providing a long-life solid-state dye laser medium is tackled. This challenge is solved by a solid-state dye laser medium comprising a polydimethylsiloxane, and a dye dissolved in the polydimethylsiloxane.
09/25/14
20140288307
Crystalline cis-(e)-4-(3-fluorophenyl)-2',3',4',9'-tetrahydro-n,n-dimethyl-2'-(1-oxo-3-phenyl-2-propenyl)-spiro[cyclohexane-1,1'[1h]-pyrido[3,4-b]indol]-4-amine
The present invention relates to crystalline forms of cis-(e)-4-(3-fluorophenyl)-2′,3′,4′,9′-tetrahydro-n,n-dimethyl-2′-(1-oxo-3-phenyl-2-propenyl)-spiro[cyclohexane-1,1′[1h]-pyrido[3,4-b]indol]-4-amine, pharmaceutical compositions and medicaments comprising these modifications, the use of these modifications as well as to a process for making the crystalline forms.. .
09/25/14
20140287011
Arthropod pest control composition
Disclosed is an arthropod pest control composition comprising 2-(2,6-difluorophenyl)-4-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydrooxazole and an inert carrier, wherein the volume median diameter of 2-(2,6-difluorophenyl)-4-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydrooxazole is from 1.5 to 5.9. .
09/25/14
20140284245
Pharmaceutical compositions of dimethyl fumarate
Pharmaceutical compositions and dosage forms of dimethyl fumarate containing low levels of certain impurities are disclosed.. .
09/25/14
20140283982
Universal nanopatternable interfacial bonding
One embodiment of the present invention provides a system for bonding a first substrate and a second substrate. During operation, the system starts by treating a first surface of the first substrate and a second surface of the second substrate with a hydrophilic treatment.
09/18/14
20140275683
Catalyst for preparing isobutene by dissociation of methyl tert-butyl ether, preparation method and use thereof
Disclosed is a catalyst for preparing isobutene by dissociation of methyl tert-butyl ether, the catalyst comprising amorphous silica alumina and a silicalite-1 molecular sieve, wherein the total ir acid amount of weak acids in the catalyst is in a range from 0.020 to 0.080 mmol/g, and the ratio of b acid/l acid of the weak acids is in a range from 2.5:1 to 4.0:1. Also provided is a method of preparing the catalyst and the use thereof.
09/18/14
20140275609
Methyl-substituted biphenyl compounds, their production and their use in the manufacture of plasticizers
In a process for producing methyl-substituted biphenyl compounds, a feed comprising at least one aromatic hydrocarbon selected from the group consisting of toluene, xylene and mixtures thereof is contacted with hydrogen in the presence of a hydroalkylation catalyst under conditions effective to produce a hydroalkylation reaction product comprising (methylcyclohexyl)toluenes and/or (dimethylcyclohexyl)xylenes. At least part of the hydroalkylation reaction product is then dehydrogenated in the presence of a dehydrogenation catalyst under conditions effective to produce a dehydrogenation reaction product comprising a mixture of methyl-substituted biphenyl compounds..
09/18/14
20140275538
Rilpivirine process
Disclosed is process for the preparation of a key rilpivirine intermediate namely, (e)-4-(2-cyanoethenyl)-2,6-dimethylphenylamine hydrochloride (ii) by a process comprising reaction of the tetrafluoroborate salt of the diazonium ion of 2,6-dimethyl-4-amino-1-carboxybenzyl phenylamine (vi) with acrylonitrile in presence of palladium acetate, followed by treatment with an acid and its subsequent conversion to the hydrochloride salt (ii), wherein the undesired z isomer is less than 0.5% and provides rilpivirine hydrochloride having z isomer less than 0.1%.. .
09/18/14
20140275291
Biocompatible and bioabsorbable derivatized chitosan compositions
The invention relates to biocompatible, bioabsorbable derivatized non-crosslinked chitosan compositions optionally crosslinked to gelatin/collagen by 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (edc) for biomedical use and methods of making and testing such compositions, including a modified acute systemic toxicity test. The compositions comprise derivatized chitosan reacetylated to a degree of n-deacetylation (dda) of between about 15% and 40%.
09/18/14
20140275190
Biocidal composition of 2,6-dimethyl-m-dioxane-4-ol acetate and methods of use
Provided is a biocidal composition comprising 2,6-dimethyl-m-dioxane-4-ol acetate and an isothiazolinone biocidal compound. The composition is useful for controlling microorganisms in aqueous or water containing systems..
09/18/14
20140275105
Crystal of androgen receptor antagonistic compound
[solution] a01-type crystal of monohydrate, a01-type crystal of hydrochloride, a01-type crystal of hydrobromide, and a01-type crystal of methanesulfonate of (2r,5s)-4-(3-chloro-4-cyanophenyl)-n-(2-cyclopropylpyrimidin-5-yl)-2,5-dimethylpiperazine-1-carboxamide, which have certain crystal forms, are provided.. .
09/18/14
20140273111
Process of preparing functionalized polymers via enzymatic catalysis
The invention relates to functionalized, telechelic polymers synthesized by enzymatic catalysis and methods, and the functionalization of polymers via michael addition with a lipase catalyst, and the crosslinking of mono- or difunctional (telechelic) polymers made by enzymatic catalysis, such as by using multifunctional coupling agents and enzyme catalysts. Quantitative transesterification of vinyl methacrylate with poly(ethylene glycol), poly(isobutylene) and poly(dimethylsiloxane) was achieved using candida antarctica lipase b.
09/18/14
20140272607
Non-aqueous electrolyte for lithium-ion battery
And r8, r9 and r10 are each independently alkyl, cycloalkyl, aryl, heterocyclyl, or heteroaryl; provided that if the organophosphorus compound is of formula ib, then at least one of r5, and r6 are other than hydrogen, alkyl, or alkenyl; and if the organophosphorus compound is of formula ic, then the electrolyte solution does not include 4-methylene-1,3-dioxolan-2-one or 4,5-dimethylene-1,3-dioxolan-2-one.. .
09/18/14
20140272603
Electrolyte additives for lithium sulfur rechargeable batteries
An electrolyte solution for a lithium sulfur battery contains a lithium oxalatoborate compound in a 0.05-2 m solution in conventional lithium sulfur battery electrolyte solvents, optionally with other lithium compounds. Examples of solvents include dimethoxyethane (dme), dioxolane, and triethyleneglycol dimethyl ether (tegdme).
09/18/14
20140272374
Process for producing composite elements
The present invention relates to a process for producing composite elements comprising at least one rigid foam layer a) and at least one outer layer b), at least comprising: provision of a flowable starting material a*) and application of the flowable starting material a*) to the outer layer b) by means of a fixed application apparatus c) while the outer layer b) is moved continuously. The starting material a*) here comprises at least one polyisocyanate, at least one polyol, at least one blowing agent, a catalyst composition comprising at least one compound d1) selected from the group consisting of metal carboxylates and n,n′,n″-tris(dimethylaminopropyl)hexahydrotriazine, and at least one compound d2) which catalyzes polyurethane formation and which differs from the compound d1) and comprises at least one amino group, and optionally auxiliaries and additives.
09/18/14
20140272327
Ink for inkjet, ink cartridge using the ink, inkjet recorder and ink recorded matter
An ink for inkjet includes water, and a mixture of hydrosoluble organic materials in an amount of from 40 to 70% by weight. The mixture of hydrosoluble organic materials includes n,n-dimethylacrylamide and/or n,n-diethylacrylamide, the total content of which is from 10 to 70% by weight based on total weight of the ink..
09/18/14
20140271904
Methods for preparing tissue implants
A method is provided for preparing a biological tissue for implantation. The method includes providing a biological tissue from a human or animal donor, treating the biological tissue with an antiviral treatment formulation, lysing the biological tissue, decellularizing the biological tissue with a decellularization treatment formulation, and decontaminating the biological tissue with an alkaline alcohol solution.
09/18/14
20140271854
Opioid receptor modulator dosage formulations
Abuse deterrent solid dosage formulations containing 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations.. .
09/18/14
20140271828
Pain reliever composition
A pain reliever comprised of dextrose, aloe vera concentrate, and some or all of the following ingredients: propylene glycol, caprylic/capric tryglicerides, sodium chloride (or acetic acid), a homeopathic anti-inflamatory extract, dimethyl sulfone (or methylsulfonylmethane (msm)), cetyl myristoleate, and, optionally, a pitcher plant extract. The resulting compositions are a water-based solution and two gel composition applied to the epidermis of mammals for relieving pain..
09/18/14
20140271794
Antimicrobial foam medical patch and method of making the same
A foam medical patch is provided including a foam substrate having integrated therein an antimicrobial material comprising a silane quaternary ammonium salt. The antimicrobial material is substantially free from arsenic, silver, tin, heavy metals and polychlorinated phenols.
09/18/14
20140271511
Method and compositions for improving wear of color cosmetics
A composition comprising at least one non-sensitizing pressure sensitive adhesive that is the polycondensate of a silanol endblocked polydimethylsiloxane and a silicate resin; at least one copolymer of vinyl pyrrolidone and a long chain alpha olefin; at least one montmorillonite mineral; and at least one volatile solvent; and a related methods and kits.. .
09/18/14
20140263665
Thermally-responsive record material
The invention describes a thermally-responsive record material substantially free of aromatic isocyanate. The record material comprises a support having provided thereon a heat-sensitive composition comprising a substantially colorless dye precursor comprising a fluoran; and a developer material selected from the group consisting of 4,4′-diaminodiphenylsulfone and 3,3′-diaminodiphenylsulfone, which upon being heated react with said dye precursor to develop color, and including a binder material.
09/11/14
20140259209
Root soaking method to produce double haploid inbred lines in corn
The subject invention pertains to a method of generating double haploid (dh) corn inbred lines from haploid corn plants. The roots of haploid corn plants are contacted with a solution/composition comprising about 0.0015m colchicine and about 0.11m dimethyl sulfoxide and the treated haploid corn plants are grown.
09/11/14
20140256960
Gene expression cassette and a transformant, and a method for manufacturing 2-deoxy-scyllo-inosose and a method for purifying 2-deoxy-scyllo-inosose using said transformant
A transformant is prepared to insert at least a gene expression cassette comprising a gene involved in the synthesis of 2-deoxy-scyllo-inosose into e. Coli as host cells.
09/11/14
20140256943
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on sert, 5-ht3 and 5-ht1a and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.. .
09/11/14
20140256853
Curing agent for low temperature cure applications
The present invention provides mannich base derivatives of n,n′-dimethyl secondary diamine polymers including mannich base derivatives of methylamine-terminated poly-(n-methylazetidine) and mannich base derivatives of methylamine-terminated poly-(n-methylazacycloheptane). Amine curing agent compositions and amine-epoxy compositions containing mannich base derivatives of n,n′-dimethyl secondary diamine polymers are also disclosed..
09/11/14
20140256777
Biocidal composition of 2,6-dimethyl-m-dioxane-4-ol acetate and methods of use
Provided is a biocidal composition comprising 2,6-dimethyl-m-dioxane-4-ol acetate and an isothiazolinone biocidal compound. The composition is useful for controlling microorganisms in aqueous or water containing systems..
09/11/14
20140256537
Addition of a base to enhance product yield in alkylation reactions
A process for making styrene including providing toluene, a co-feed, and a c1 source to a reactor containing a catalyst having acid sites and reacting toluene with the c1 source in the presence of the catalyst and the co-feed to form a product stream containing ethylbenzene and styrene, wherein the c1 source is selected from methanol, formaldehyde, formalin, trioxane, methylformcel, paraformaldehyde, methylal, dimethyl ether, and wherein the co-feed removes at least a portion of the acid sites on the catalyst. The co-feed can be selected from the group of aniline, amines, cresol, anisol, and combinations thereof..
09/11/14
20140256382
Cellular telephones and touch screen displays having anti-microbial coatings
A touch screen and a cellular telephone are provided that may include one or more surfaces coated with an antimicrobial treatment, which may include a silane quaternary ammonium salt and isopropyl alcohol. The silane quaternary ammonium salt may initially include an unreacted organofunctional silane that subsequently reacts with and covalently bonds to the surfaces of the touch screen, such as 3-(trimethoxysilyl) propyldimethyloctadecyl ammonium chloride.
09/11/14
20140255505
Pazopanib formulation
A granulation formulation of 5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide or pharmaceutically acceptable salt thereof, which is adapted for reconstitution with an aqueous vehicle, and associated oral suspension.. .
09/11/14
20140255483
Pharmaceutical composition and administrations thereof
The present invention relates to pharmaceutical compositions containing a solid dispersion of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.. .
09/11/14
20140255453
Herbal ointment for musculoskeletal and joint-related conditions
An herbal ointment. The herbal ointment may include about 40-45 weight percent of herb-infused oil, water or alcohol, or any desired combination thereof, about 30 weight percent purified water, about 10 weight percent emulsifier wax, about 5-10 weight percent menthol, about 3 weight percent dimethyl isosorbide, about 2 weight percent glycerin, about 2 weight percent hydrogenated methyl abietate, about 0.5 weight percent lonicera caprifolium and lonicera japanica extract, about 0.5 weight percent tocopherol, about 0.35 weight percent vanillyl butyl ether, about 0.35 weight percent xanthan gum, about 0.3 weight percent citric acid 50% aqueous solution, and about 0.25 weight percent menthyl lactate, the herb-infused oil, water or alcohol including a 1:5 dilution of herbal extracts in a solvent, wherein the herbal extracts are of german chamomile (matricaria recutita), valerian (valeriana officinalis), ginger (zingiber officinale roscoe), peppermint (mentha.times.piperita), feverfew (tanacetum parthenium), and lemon balm (melissa officinalis).
09/11/14
20140255326
Solvent formulations
The present disclosure provides, in part, a solvent composition including an an acetic acid alkyl (c1-c4) ester (e.g., methyl acetate (ma), ethyl acetate (ea), or tert-butyl acetate (tbac)) and a carbonate ester (e.g., dimethyl carbonate, or propylene carbonate). .
09/04/14
20140249291
Method of making integrated ion membrane sealing ring assembly
A method of making a sealing ring ion membrane integrated component, includes: mixing and stirring sulfonic resin with dimethylformamide; filtering the mixed liquid; placing the filtrate in a plastic container for precipitating; the sealing ring into a worktable of a drying apparatus; pouring the precipitated filtrate into the worktable of the drying apparatus, and vacuuming while drying; and taking the dried integrated ion membrane sealing ring assembly out of the drying apparatus, and then cooling the assembly.. .
09/04/14
20140249117
Active ingredient combination of a retinoid and a hormone combination with contraceptive action as medicament for treatment of skin diseases
The present invention relates to a medicament, the active ingredient combination of which consists of a retinoid selected from the group consisting of acitretin [9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid], etretinate [ethyl 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate], isotretinoin [3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid] and tretinoin [3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid] and of a hormone combination with contraceptive action of an oestrogen component and a gestagen component, and to a dosage form consisting of at least 28 daily units, of which the final 7-3 daily units contain only the retinoid as active ingredient and the other daily units also contain the hormone-containing active ingredient combination, and to the use thereof for treating acne, seborrhoea or psoriasis.. .
09/04/14
20140248772
Method for tuning a deposition rate during an atomic layer deposition process
Embodiments of the invention provide methods for depositing a material on a substrate within a processing chamber during a vapor deposition process, such as an atomic layer deposition (ald) process. In one embodiment, a method is provided which includes sequentially exposing the substrate to a first precursor gas and at least a second precursor gas while depositing a material on the substrate during the ald process, and continuously or periodically exposing the substrate to a treatment gas prior to and/or during the ald process.
09/04/14
20140248356
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on sert, 5-ht3 and 5-ht1a and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.. .
09/04/14
20140248355
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on sert, 5-ht3 and 5-ht1a and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.. .
08/28/14
20140243564
Method for inhibiting fouling in basic washing systems
Fouling in basic washing systems such as caustic scrubbers can be prevented or at least mitigated by treating the liquid washing phase used in a caustic scrubber with an additive having at least one compound selected from the group consisting of oxalyl dihydrazide, a disulfite salt, isopropyl hydroxylamine, chlorobenzhydrazide, aminobenzhydrazide, a thiosulfate salt, 4,4-dimethyl oxazolidine, a hydrosulfite salt, and mixtures thereof, particularly in the case where the liquid washing phase includes components that may undergo an aldol condensation, the products of which may cause fouling solids and/or sludges.. .
08/28/14
20140243361
Polymorphs of arry-380, a selective herb2 inhibitor and pharmaceutical compositions contianing them
Polymorphs of n4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-n6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. Processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed..


Popular terms: [SEARCH]

Dimethyl topics: Physiologic, Hydrochloric Acid, Fresnel Zone, Aberration, Ophthalmic, Liquid Crystal, Imaging System, Pharmaceutically Acceptable Salt, Pharmaceutically Acceptable Salts, Chloric Acid, Tartaric Acid, Fumaric Acid, Antagonist, Bradykinin, Enantiomer

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Dimethyl for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Dimethyl with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.3284

3205

2 - 1 - 71